Description

Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations.

Resources

Name	Format	Description	Link
Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/guidance-industry-standards-clinical-trials-type-2-diabetes-canada.html#a11
Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/ligne-directrice-normes-applicables-essais-cliniques-diabete-type-2-canada.html#a11

Tags

Topics

Categories